Immunogenicity 15042
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
AGAP1
Transcript ID
uc002vvt.3
HLA INFO
A*02:01
TCR INFO
No TCR info found!
Full length protein sequence (804 aa)
MNYQQ
1
QLANS
6
AAIRA
11
EIQRF
16
ESVHP
21
NIYSI
26
YELLE
31
RVEEP
36
VLQNQ
41
IREHV
46
IAIED
51
AFVNS
56
QEWTL
61
SRSVP
66
ELKVG
71
IVGNL
76
ASGKS
81
ALVHR
86
YLTGT
91
YVQEE
96
SPEGG
101
RFKKE
106
IVVDG
111
QSYLL
116
LIRDE
121
GGPPE
126
AQFAM
131
WVDAV
136
IFVFS
141
LEDEI
146
SFQTV
151
YHYYS
156
RMANY
161
RNTSE
166
IPLVL
171
VGTQD
176
AISSA
181
NPRVI
186
DDARA
191
RKLSN
196
DLKRC
201
TYYET
206
CATYG
211
LNVER
216
VFQDV
221
AQKIV
226
ATRKK
231
QQLSI
236
GPCKS
241
LPNSP
246
SHSSV
251
CSAQV
256
SAVHI
261
SQTSN
266
GGGSL
271
SDYSS
276
SVPST
281
PSTSQ
286
KELRI
291
DVPPT
296
ANTPT
301
PVRKQ
306
SKRRS
311
NLFTS
316
RKGSD
321
PDKEK
326
KGLES
331
RADSI
336
GSGRA
341
IPIKQ
346
GMLLK
351
RSGKS
356
LNKEW
361
KKKYV
366
TLCDN
371
GVLTY
376
HPSLH
381
DYMQN
386
VHGKE
391
IDLLR
396
TTVKV
401
PGKRP
406
PRATS
411
ACAPI
416
SSPKT
421
NGLSK
426
DMSSL
431
HISPN
436
SDTGL
441
GDSVC
446
SSPSI
451
SSTTS
456
PKLDP
461
PPSPH
466
ANRKK
471
HRRKK
476
STSNF
481
KADGL
486
SGTAE
491
EQEEN
496
FEFII
501
VSLTG
506
QTWHF
511
EATTY
516
EERDA
521
WVQAI
526
ESQIL
531
ASLQS
536
CESSK
541
NKSRL
546
TSQSE
551
AMALQ
556
SIRNM
561
RGNSH
566
CVDCE
571
TQNPN
576
WASLN
581
LGALM
586
CIECS
591
GIHRN
596
LGTHL
601
SRVRS
606
LDLDD
611
WPVEL
616
IKVMS
621
SIGNE
626
LANSV
631
WEESS
636
QGRTK
641
PSVDS
646
TREEK
651
ERWIR
656
AKYEQ
661
KLFLA
666
PLPCT
671
ELSLG
676
QHLLR
681
ATADE
686
DLRTA
691
ILLLA
696
HGSRD
701
EVNET
706
CGEGD
711
GRTAL
716
HLACR
721
KGNVV
726
LAQLL
731
IWYGV
736
DVTAR
741
DAHGN
746
TALAY
751
ARQAS
756
SQECI
761
DVLLQ
766
YGCPD
771
ERFVL
776
MATPN
781
LSRRN
786
NNRNN
791
SSGRV
796
PTII
801
Mutation Information
DNA mutation:
None
Peptide Range:
567 ~ 591
Mut AA position:
632 (13 in Wild Type peptide)
Alignment
Wild Type:
"GNSHCVDCETQNPNWASLNLGALMC
||||||||||||.||||||||||||
Mutant:
GNSHCVDCETQNSNWASLNLGALMC"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) AGAP1
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay